From Our Partners
Monday, July 4, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Funding News

DTRA Biodefense Grand Challenge Sources Announced

by Global Biodefense Staff
February 18, 2013

Infectious diseases have a range of negative effects on military operations that impede combat effectiveness and increase the logistical burden for diagnosis, treatment, and evacuation. Because of the complexity of these problems, the Defense Threat Reduction Agency (DTRA) believes an open innovation development “Grand Challenge” strategy is most likely to quickly yield a set of disruptive solutions. 

In November, the agency issued a formal Request for Information seeking sources under the “Open Innovation Services for Prizes and Challenges” effort to assist DTRA staff in defining, developing, advertising, and administering a large market stimulatory grand challenge aimed at solving problems in science and engineering related to point-of-care or point-of-need diagnostics for known, emerging, or engineered pathogens.  

This week DTRA announced an intention to enter into limited competition between responding sources “X Prize Foundation” and the team of “Booz-Allen-Hamilton / Innocentive, Inc.” for the effort. 

The grand challenge is defined as a reduction-to-practice challenge with a prize not to exceed $10M. The effort requires sources to conduct deep research to identify current research and development (R&D) investments salient to the challenge topic and, in doing so, identify fundamental science, engineering, or commercial barriers to solving problems salient to the challenge. 

As a core requirement of the contract, the organizer must be able to access a technically capable community in the biological, healthcare, chemical, microelectronics sciences fields who can contribute to the challenge solution.  Once the grand challenge metrics for measuring solutions and the prize amount are identified, the organizing entity must facilitate a large-scale public awareness campaign. 

The contract will also require the source to perform testing and evaluation (T&E) of submitted solutions during administration of the challenge. As the challenge will directly relate to the biodefense countermeasures, certain classes of solutions must be cleared by the Food and Drug Administration and will require the T&E to be conducted in a manner conducive to such goals. 

The anticipated award date is June 28, 2013. The announcement was made under Solicitation Number: HDTRA1-13-R-0012.

From Our Partners
Tags: AwardsDefense Threat Reduction AgencyPOC Diagnostics

Related Posts

Biodefense Industry News
Industry News

Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs

June 20, 2022
Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors
Industry News

Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors

May 26, 2022
NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories
Biosecurity

Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories

May 5, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC